1200.06 Efficacy And Safety of Obicetrapib in Lowering Atherogenic Lipid Levels: A Dose-Response Meta-Analysis
JACC: Cardiovascular Interventions · 2026-03 · 19 (5) · S53
DOI: 10.1016/j.jcin.2026.01.181 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JACC: Cardiovascular Interventions, 2026-03. Verfasst von Omar Abdullah Gill und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gill, O. A., Pathak, P., Monterrubio, M. L. S., Ahmed, A., Habib, S. E., ELABDI, K., Khatib, B. A., Vema, S., Prattipati, P. S. S., Bodla, V. T. S., Patel, J., Asha, T., Parsa, S., Woldu, D., & Kataveni, S. (2026). 1200.06 Efficacy And Safety of Obicetrapib in Lowering Atherogenic Lipid Levels: A Dose-Response Meta-Analysis. JACC: Cardiovascular Interventions, 19(5), S53. https://doi.org/10.1016/j.jcin.2026.01.181
Vancouver
Gill OA, Pathak P, Monterrubio MLS, Ahmed A, Habib SE, ELABDI K, et al. 1200.06 Efficacy And Safety of Obicetrapib in Lowering Atherogenic Lipid Levels: A Dose-Response Meta-Analysis. JACC: Cardiovascular Interventions. 2026;19(5):S53. doi:10.1016/j.jcin.2026.01.181
BibTeX
@article{Gill2026,
author = {Gill, Omar Abdullah and Pathak, Prutha and Monterrubio, Miguel Leonardo Salcedo and Ahmed, Afreen and Habib, Syeda Erum and ELABDI, Khalil and Khatib, Basel Al and Vema, Saisunil and Prattipati, Pramoda Sai Sudha and Bodla, Venkat Tej Sai and Patel, Jahnavi and Asha, Tanzin and Parsa, Syeda and Woldu, Dori and Kataveni, Suhas},
title = {1200.06 Efficacy And Safety of Obicetrapib in Lowering Atherogenic Lipid Levels: A Dose-Response Meta-Analysis},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {5},
pages = {S53},
doi = {10.1016/j.jcin.2026.01.181}
}
EUVIMED